1342PEfficacy of talimogene laherparepvec (T-VEC) in melanoma patients (pts) with locoregional (LR) recurrence, including in-transit metastases (ITM): Subgroup analysis of the phase III OPTiM study
Middleton, M R, Harrington, K, Ross, M, Ohrling, K, Radcliffe, H-S, Collichio, FVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz255.031
Date:
October, 2019
File:
PDF, 91 KB
2019